However, CF-NBS also results in cases where the diagnosis remains uncertain, categorized as Cystic Fibrosis Screen Positive Inconclusive Diagnosis/CFTR-related Metabolic Syndrome (CFSPID/CRMS), posing a significant clinical challenge [4,5]. This evidence concerns the gene CFTR and metabolic syndrome.